April 24, 2023, 12:44 a.m. | Nicholas T. Runcie, Antonia S. J. S. Mey

stat.ML updates on arXiv.org arxiv.org

Computationally generating novel synthetically accessible compounds with high
affinity and low toxicity is a great challenge in drug design. Machine-learning
models beyond conventional pharmacophoric methods have shown promise in
generating novel small molecule compounds, but require significant tuning for a
specific protein target. Here, we introduce a method called selective iterative
latent variable refinement (SILVR) for conditioning an existing diffusion-based
equivariant generative model without retraining. The model allows the
generation of new molecules that fit into a binding site of …

arxiv beyond bio challenge design diffusion drug design generative iterative low machine molecules novel protein small toxicity

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Data Scientist

@ Publicis Groupe | New York City, United States

Bigdata Cloud Developer - Spark - Assistant Manager

@ State Street | Hyderabad, India